Most of the symptoms of COVID-19 are a result of an overactive immune system response resulting in cytokines (which are the body’s anti-inflammatory cells) which indiscriminately cause inflammation and problems with many or all of the organs in the body. This is the same mechanism that occurs in many autoimmune disorders such as systemic lupus erythematosus (SLE), vasculitis, rheumatoid arthritis, and several other conditions which are routinely treated by a rheumatologist such as Dr. Norman Gaylis and his associates, using multiple treatments ranging from corticosteroids to biologic drugs.
Based on our experience at AARDS of this immune inflammatory behavior, we have been treating several COVID-19 “long haul” patients with a similar approach with treatment choices tailored to the particular presentation of each patient’s symptoms. We are also optimistic that in the near future we will be able to have the opportunity to start treating long haul patients with a unique monoclonal antibody through a clinical research study currently under review by the FDA.
Once this clinical trial is approved, in addition to our current treatment options, we will begin enrolling in the next few months and treating long haul patients who have previously tested positive for COVID-19 and continue to have symptoms in the hopes of offering some relief of their symptoms.
Telemedicine Available for Covid Long Haulers who live within driving distance to the office as a follow-up in person visit is needed if you suffer from Covid Long hauler symptoms.
“I notice a big difference in energy and mental clarity and I feel 100% back to normal at this point”
“2 years of symptoms, pain and dysfunction, are resolving. Most of my pain is gone, energy level greatly improved and fog reduced”